Cargando…

Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer

PURPOSE: Several predictive models have been developed to predict the pathological complete response (pCR) after neoadjuvant chemotherapy (NAC); however, few are broadly applicable owing to radiologic complexity and institution-specific clinical variables, and none have been externally validated. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Ji-Jung, Kim, Eun-Kyu, Kang, Eunyoung, Kim, Jee Hyun, Kim, Se Hyun, Suh, Koung Jin, Kim, Sun Mi, Jang, Mijung, Yun, Bo La, Park, So Yeon, Lim, Changjin, Han, Wonshik, Shin, Hee-Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475713/
https://www.ncbi.nlm.nih.gov/pubmed/37272242
http://dx.doi.org/10.4048/jbc.2023.26.e14
_version_ 1785100774029656064
author Jung, Ji-Jung
Kim, Eun-Kyu
Kang, Eunyoung
Kim, Jee Hyun
Kim, Se Hyun
Suh, Koung Jin
Kim, Sun Mi
Jang, Mijung
Yun, Bo La
Park, So Yeon
Lim, Changjin
Han, Wonshik
Shin, Hee-Chul
author_facet Jung, Ji-Jung
Kim, Eun-Kyu
Kang, Eunyoung
Kim, Jee Hyun
Kim, Se Hyun
Suh, Koung Jin
Kim, Sun Mi
Jang, Mijung
Yun, Bo La
Park, So Yeon
Lim, Changjin
Han, Wonshik
Shin, Hee-Chul
author_sort Jung, Ji-Jung
collection PubMed
description PURPOSE: Several predictive models have been developed to predict the pathological complete response (pCR) after neoadjuvant chemotherapy (NAC); however, few are broadly applicable owing to radiologic complexity and institution-specific clinical variables, and none have been externally validated. This study aimed to develop and externally validate a machine learning model that predicts pCR after NAC in patients with breast cancer using routinely collected clinical and demographic variables. METHODS: The electronic medical records of patients with advanced breast cancer who underwent NAC before surgical resection between January 2017 and December 2020 were reviewed. Patient data from Seoul National University Bundang Hospital were divided into training and internal validation cohorts. Five machine learning techniques, including gradient boosting machine (GBM), support vector machine, random forest, decision tree, and neural network, were used to build predictive models, and the area under the receiver operating characteristic curve (AUC) was compared to select the best model. Finally, the model was validated using an independent cohort from Seoul National University Hospital. RESULTS: A total of 1,003 patients were included in the study: 287, 71, and 645 in the training, internal validation, and external validation cohorts, respectively. Overall, 36.3% of the patients achieved pCR. Among the five machine learning models, the GBM showed the highest AUC for pCR prediction (AUC, 0.903; 95% confidence interval [CI], 0.833–0.972). External validation confirmed an AUC of 0.833 (95% CI, 0.800–0.865). CONCLUSION: Commonly available clinical and demographic variables were used to develop a machine learning model for predicting pCR following NAC. External validation of the model demonstrated good discrimination power, indicating that routinely collected variables were sufficient to build a good prediction model.
format Online
Article
Text
id pubmed-10475713
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Breast Cancer Society
record_format MEDLINE/PubMed
spelling pubmed-104757132023-09-05 Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer Jung, Ji-Jung Kim, Eun-Kyu Kang, Eunyoung Kim, Jee Hyun Kim, Se Hyun Suh, Koung Jin Kim, Sun Mi Jang, Mijung Yun, Bo La Park, So Yeon Lim, Changjin Han, Wonshik Shin, Hee-Chul J Breast Cancer Original Article PURPOSE: Several predictive models have been developed to predict the pathological complete response (pCR) after neoadjuvant chemotherapy (NAC); however, few are broadly applicable owing to radiologic complexity and institution-specific clinical variables, and none have been externally validated. This study aimed to develop and externally validate a machine learning model that predicts pCR after NAC in patients with breast cancer using routinely collected clinical and demographic variables. METHODS: The electronic medical records of patients with advanced breast cancer who underwent NAC before surgical resection between January 2017 and December 2020 were reviewed. Patient data from Seoul National University Bundang Hospital were divided into training and internal validation cohorts. Five machine learning techniques, including gradient boosting machine (GBM), support vector machine, random forest, decision tree, and neural network, were used to build predictive models, and the area under the receiver operating characteristic curve (AUC) was compared to select the best model. Finally, the model was validated using an independent cohort from Seoul National University Hospital. RESULTS: A total of 1,003 patients were included in the study: 287, 71, and 645 in the training, internal validation, and external validation cohorts, respectively. Overall, 36.3% of the patients achieved pCR. Among the five machine learning models, the GBM showed the highest AUC for pCR prediction (AUC, 0.903; 95% confidence interval [CI], 0.833–0.972). External validation confirmed an AUC of 0.833 (95% CI, 0.800–0.865). CONCLUSION: Commonly available clinical and demographic variables were used to develop a machine learning model for predicting pCR following NAC. External validation of the model demonstrated good discrimination power, indicating that routinely collected variables were sufficient to build a good prediction model. Korean Breast Cancer Society 2023-03-28 /pmc/articles/PMC10475713/ /pubmed/37272242 http://dx.doi.org/10.4048/jbc.2023.26.e14 Text en © 2023 Korean Breast Cancer Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jung, Ji-Jung
Kim, Eun-Kyu
Kang, Eunyoung
Kim, Jee Hyun
Kim, Se Hyun
Suh, Koung Jin
Kim, Sun Mi
Jang, Mijung
Yun, Bo La
Park, So Yeon
Lim, Changjin
Han, Wonshik
Shin, Hee-Chul
Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
title Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
title_full Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
title_fullStr Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
title_full_unstemmed Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
title_short Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
title_sort development and external validation of a machine learning model to predict pathological complete response after neoadjuvant chemotherapy in breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475713/
https://www.ncbi.nlm.nih.gov/pubmed/37272242
http://dx.doi.org/10.4048/jbc.2023.26.e14
work_keys_str_mv AT jungjijung developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT kimeunkyu developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT kangeunyoung developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT kimjeehyun developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT kimsehyun developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT suhkoungjin developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT kimsunmi developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT jangmijung developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT yunbola developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT parksoyeon developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT limchangjin developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT hanwonshik developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer
AT shinheechul developmentandexternalvalidationofamachinelearningmodeltopredictpathologicalcompleteresponseafterneoadjuvantchemotherapyinbreastcancer